Specifications - Lonza Biologics Plant Expansion, Portsmouth, NH, USA

Key Data
Order year	2000
Project type	Facility expansion
Location	New Hampshire, USA
Estimated investment	$207m, phase three $300m (€220m)
Completion	August 2004, Phase three mid-2008
Key Players
Sponsor	Lonza Biologics
Lead contractor	Parsons, US (www.parsons.com)
Subcontractors	Emerson Process Management, US
	Kinetics Modular Systems (KMS), US
	PROCONEX, US
	New England Controls, US
	Appledore Engineering
Output chemicals	Therapeutic proteins and monoclonal antibodies
Units/tablets (year)	Phase two quadrupled capacity and now phase three is addressing mid-scale production
Featured Suppliers
Applikon Biotechnology - Bioreactor Systems